Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine and Rituximab in Older Untreated DLBCL
NCT01234467Phase 2Completed
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- Mar 2011
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine in diffuse large B-cell lymphoma (DLBCL), sponsored by UNC Lineberger Comprehensive Cancer Center. Started Mar 2011; status: completed.
02
Drugs
bendamustine
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT01234467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01234467.